These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 88775)

  • 41. [Acute intermittent porphyria: uroporphyrinogen-I-synthetase activity in erythrocytes as a diagnostic index].
    Formgren B; Wetterberg L
    Lakartidningen; 1978 May; 75(19):1921-4. PubMed ID: 651454
    [No Abstract]   [Full Text] [Related]  

  • 42. Why is the patient with acute intermittent porphyria not light sensitive?
    Wetterberg L; Thunell S; Zetterlund P
    Acta Derm Venereol Suppl (Stockh); 1982; 100():73-4. PubMed ID: 6962637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.
    Anderson PM; Reddy RM; Anderson KE; Desnick RJ
    J Clin Invest; 1981 Jul; 68(1):1-12. PubMed ID: 7251856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uroporphyrinogen synthetase in erythrocytes. Its diagnostic value in latent acute intermittent porphyria with special regard to the gene penetrance.
    With TK; Pedersen JS
    Dan Med Bull; 1981 Mar; 28(1):27-34. PubMed ID: 7238130
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter: HBAg and acute intermittent porphyria.
    Milcov V; Babes VT; Szábo K
    Lancet; 1974 May; 1(7863):934-5. PubMed ID: 4133459
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute intermittent porphyria: detection of carriers.
    Kreimer-Birnbaum M; Franco-Saenz R; White P
    Monogr Hum Genet; 1978; 10():227-34. PubMed ID: 723899
    [No Abstract]   [Full Text] [Related]  

  • 47. Is hepatoerythropoietic porphyria a homozygous form of porphyria cutanea tarda? Inheritance of uroporphyrinogen decarboxylase deficiency in a Spanish family.
    Lazaro P; de Salamanca RE; Elder GH; Villaseca ML; Chinarro S; Jaqueti G
    Br J Dermatol; 1984 May; 110(5):613-7. PubMed ID: 6722030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Markers for vulnerability in acute porphyria. A hypothesis paper.
    Thunell S; Andersson C; Carlmark B; Floderus Y; Grönqvist SO; Harper P; Henrichson A; Lindh U
    Eur J Clin Chem Clin Biochem; 1995 Apr; 33(4):179-94. PubMed ID: 7626691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
    Doss MO
    Clin Genet; 1989 Feb; 35(2):146-51. PubMed ID: 2721023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial and sporadic porphyria cutanea: two different diseases.
    de Verneuil H; Aitken G; Nordmann Y
    Hum Genet; 1978 Oct; 44(2):145-51. PubMed ID: 730158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Porphyria cutanea tarda in three generations of a single family.
    Benedetto AV; Kushner JP; Taylor JS
    N Engl J Med; 1978 Feb; 298(7):358-62. PubMed ID: 622106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria.
    Llewellyn DH; Elder GH; Kalsheker NA; Marsh OW; Harrison PR; Grandchamp B; Picat C; Nordmann Y; Romeo PH; Goossens M
    Lancet; 1987 Sep; 2(8561):706-8. PubMed ID: 2888941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute intermittent porphyria: laboratory diagnosis by molecular methods.
    Schreiber WE
    Clin Lab Med; 1995 Dec; 15(4):943-56. PubMed ID: 8838232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chester porphyria: biochemical studies of a new form of acute porphyria.
    McColl KE; Thompson GG; Moore MR; Goldberg A; Church SE; Qadiri MR; Youngs GR
    Lancet; 1985 Oct; 2(8459):796-9. PubMed ID: 2864531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linkage relations of acute intermittent porphyria.
    Berg K; Wetterberg L; Beckman L; Hornberg M
    Hum Hered; 1969; 19(1):1-19. PubMed ID: 5798079
    [No Abstract]   [Full Text] [Related]  

  • 57. Latent porphyria in members of the immediate family of a patient with acute intermittent porphyria.
    TAYLOR AM
    Cleve Clin Q; 1963 Jan; 30():17-20. PubMed ID: 13993545
    [No Abstract]   [Full Text] [Related]  

  • 58. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F; Wernet P; Kömpf J; Bissbort S; Göhler F
    Hum Genet; 1978 Nov; 44(3):321-31. PubMed ID: 730170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-GLO linkage analysis in 57 informative families.
    Hansen HE; Eriksen B
    Hum Hered; 1979; 29(6):355-60. PubMed ID: 511191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.